Perhaps this management all go back to thier homes of high paying pharma jobs and we get new ceo/management who forego salary with high equity participation. Company could save several million dollars from these salaries over the coming year& capital be redeployed for studies for approval when sp will then rocket. Lets call it Code red2.0 and get hotcopper and shareholders to vote on it.
Aortic Vale publications form Berlin and Munich Hospitals, page-25
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.70 |
Change
-1.350(7.92%) |
Mkt cap ! $301.7M | |||
| Open | High | Low | Value | Volume |
| $16.50 | $16.50 | $15.52 | $571.1K | 35.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13 | $15.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.00 | 775 | 2 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |